I think that what the thread over the lifetime of the product demonstrates is that "from little things, big things grow" (ack Paul Kelly). To get shelf space in dominant retailers is a great achievement and the resultant sales increase is impressive.
We will see the same progression with NXS clinical products..... a groundswell of adoption by surgeons who are generally conservative....not early adopters. They want evidence based research before they will take professional risks.
- Forums
- ASX - By Stock
- Ann: Launch of Online Sales of Next Science Acne Cream
I think that what the thread over the lifetime of the product...
Featured News
Add NXS (ASX) to my watchlist
|
|||||
Last
26.5¢ |
Change
-0.010(3.64%) |
Mkt cap ! $77.29M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 25.5¢ | $41.52K | 156.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 2488 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.260 |
3 | 41239 | 0.250 |
2 | 85413 | 0.240 |
3 | 11939 | 0.230 |
5 | 132255 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 2488 | 1 |
0.270 | 50000 | 1 |
0.275 | 17850 | 2 |
0.280 | 13571 | 2 |
0.285 | 75660 | 1 |
Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online